Serum hyaluronic acid for the screening of progressive nonalcoholic steatohepatitis in children: A promising approach

Translational Research

Volumn 156, Issue 4, 2010, Pages 226-228

  Valenti, Luca ^a   Dongiovanni, Paola ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; BIOLOGICAL MARKER;

CHILD; CHILDHOOD DISEASE; COST; DISEASE COURSE; DISEASE SEVERITY; FATTY LIVER; HUMAN; LABORATORY TEST; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; NOTE; PRIORITY JOURNAL; RISK FACTOR; SCREENING TEST; SERUM; BLOOD; COMPLICATION; MASS SCREENING; PROCEDURES;

BIOLOGICAL MARKERS; CHILD; FATTY LIVER; HUMANS; HYALURONIC ACID; LIVER CIRRHOSIS; MASS SCREENING;

EID: 77957294376     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2010.06.004     Document Type: Note

References (19)

1. S. Bellentani, G. Saccoccio, and F. Masutti Prevalence of and risk factors for hepatic steatosis in Northern Italy Ann Intern Med 132 2000 112 117 (Pubitemid 30044177)
2. J.D. Browning, L.S. Szczepaniak, and R. Dobbins Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395 (Pubitemid 39657013)
3. V. Nobili, C. Day, and N.A.F.L.D. Childhood a ticking time-bomb? Gut 58 2009 1442
4. H.M. Patton, C. Sirlin, C. Behling, M. Middleton, J.B. Schwimmer, and J.E. Lavine Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research J Pediatr Gastroenterol Nutr 43 2006 413 427 (Pubitemid 44568999)
5. D. Papandreou, I. Rousso, and I. Mavromichalis Update on non-alcoholic fatty liver disease in children Clin Nutr 26 2007 409 415 (Pubitemid 47091479)
6. W. Dunn, and J.B. Schwimmer The obesity epidemic and nonalcoholic fatty liver disease in children Curr Gastroenterol Rep 10 2008 67 72
7. M. Manco, M. Marcellini, R. Devito, D. Comparcola, M.R. Sartorelli, and V. Nobili Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis Int J Obes (Lond) 32 2008 381 387 (Pubitemid 351271778)
8. E. Bugianesi, N. Leone, and E. Vanni Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma Gastroenterology 123 2002 134 140 (Pubitemid 34747534)
9. C.P. Day From fat to inflammation Gastroenterology 130 2006 207 210
10. L.A. Adams, J.F. Lymp, and J. St Sauver The natural history of nonalcoholic fatty liver disease: a population-based cohort study Gastroenterology 129 2005 113 121 (Pubitemid 41002048)
11. M. Ekstedt, L.E. Franzen, and U.L. Mathiesen Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873 (Pubitemid 46489550)
12. A.L. Fracanzani, L. Valenti, and E. Bugianesi The risk of severe liver disease in NAFLD with normal aminotransferase levels: a role for insulin resistance and diabetes Hepatology 48 2008 792 798
13. A. Wieckowska, N.N. Zein, L.M. Yerian, A.R. Lopez, A.J. McCullough, and A.E. Feldstein In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease Hepatology 44 2006 27 33 (Pubitemid 44049136)
14. M. Pinzani, K. Rombouts, and S. Colagrande Fibrosis in chronic liver diseases: diagnosis and management J Hepatol 42 suppl 1 2005 S22 S36 (Pubitemid 40364601)
15. W.M. Rosenberg, M. Voelker, and R. Thiel Serum markers detect the presence of liver fibrosis: a cohort study Gastroenterology 127 2004 1704 1713 (Pubitemid 39575849)
16. V. Nobili, A. Alisi, A. Vania, C. Tiribelli, A. Pietrobattista, and G. Bedogni The pediatric NAFLD fibrosis index: a predictor of liver fibrosis in children with non-alcoholic fatty liver disease BMC Med 7 2009 21
17. V. Nobili, A. Alisi, and G. Torre Hyaluronic acid predicts hepatic fibrosis in children with nonalcoholic fatty liver disease Trans Res. 156 2010 229 234
18. L. Valenti, A. Al-Serri, and A.K. Daly Homozygosity for the PNPLA3 / adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
19. Romeo S, Sentinelli F, Cambuli VM, et al. The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol. In press.